{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T15:43:06Z","timestamp":1789746186856,"version":"4.0.1"},"reference-count":19,"publisher":"Informa UK Limited","issue":"3","funder":[{"name":"funding agency"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Orbit"],"published-print":{"date-parts":[[2019,5,4]]},"DOI":"10.1080\/01676830.2018.1490439","type":"journal-article","created":{"date-parts":[[2018,7,9]],"date-time":"2018-07-09T18:27:06Z","timestamp":1531160826000},"page":"244-247","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":17,"title":["Pembrolizumab and epacadostat induced fatal myocarditis and myositis presenting as a case of ptosis and ophthalmoplegia"],"prefix":"10.1080","volume":"38","author":[{"given":"Justin B.","family":"Hellman","sequence":"first","affiliation":[{"name":"Department of Ophthalmology and Vision Science, University of California Davis Health Eye Center, Sacramento, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilana","family":"Traynis","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Vision Science, University of California Davis Health Eye Center, Sacramento, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lily Koo","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Vision Science, University of California Davis Health Eye Center, Sacramento, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2018,7,9]]},"reference":[{"key":"cit0001","unstructured":"Search of: pembrolizumab [Internet]. Clinicaltrials.gov. https:\/\/clinicaltrials.gov\/ct2\/results?term=pembrolizumab. Accessed July 8, 2017."},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60958-2"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-2272"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv383"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-017-0835-0"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1503093"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2016.02.024"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2017.01.002"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw126"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2016.06.234"},{"key":"cit0011","unstructured":"A Phase 1\/2 study exploring the safety, tolerability, and efficacy of pembrolizumab (MK-3475) in combination with Epacadostat (INCB024360) in subjects with selected cancers (INCB 24360-202\/MK-3475-037\/KEYNOTE-037\/ECHO-202) - Clinicaltrials.gov. 2017. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02178722. Accessed July 9, 2017."},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504030"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611299"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-016-0152-y"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-015-0057-1"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200694"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1609214"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2017.05.041"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.2174\/0929867324666170407125017"}],"container-title":["Orbit"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/01676830.2018.1490439","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T15:03:07Z","timestamp":1677682987000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/01676830.2018.1490439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,9]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,5,4]]}},"alternative-id":["10.1080\/01676830.2018.1490439"],"URL":"https:\/\/doi.org\/10.1080\/01676830.2018.1490439","relation":{},"ISSN":["0167-6830","1744-5108"],"issn-type":[{"value":"0167-6830","type":"print"},{"value":"1744-5108","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,9]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iorb20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iorb20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-02-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-06-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}